News | December 23, 2022
Strides Pharma Global receives AUD 94 mn for sale of Australia's operations
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
Sanjeev is currently the Country President for AstraZeneca Malaysia
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The approval further strengthens the Potassium Chloride franchise for the company.
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.
_256_384.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
Subscribe To Our Newsletter & Stay Updated
